Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02621476 · ClinicalTrials.gov registry record · NA
Encouraging Mail Order Pharmacy Use to Improve Outcomes and Reduce Disparities
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 63,012
- Enrollment target
NCT02621476: Completed NA study, sponsored by Kaiser Permanente.
NCT02621476 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 63,012 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (4391% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02621476, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 63,012 participants
- Enrollment target
Study Summary
The investigators propose a randomized encouragement trial to encourage use of the existing mail order pharmacy services among diabetes patients with poor adherence to CVD risk factor medications in 3 health care systems: Kaiser Permanente Northern California, Harvard Pilgrim, and Kaiser Permanente Hawaii.
Primary Outcome
users of the mail order pharmacy service - if they utilized the mail order system to deliver medications anytime in the 12 months following the date of outreach into the intervention
Interventions
- BEHAVIORAL Usual care
- BEHAVIORAL Standardized intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63,012 participants |
| Start Date | 2017-02-01 |
| Est. Completion | 2022-05-30 |
| Phase | NA |
What the finished NCT02621476 record still lists
NCT02621476 is an interventional study that assigns participants to a tested intervention. Its 63,012 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (4391% higher).
The record links to 0 conditions, and to 2 interventions - of which Usual care is the first listed.
NCT02621476 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02621476 about?
NCT02621476 is a clinical study titled "Encouraging Mail Order Pharmacy Use to Improve Outcomes and Reduce Disparities". The investigators propose a randomized encouragement trial to encourage use of the existing mail order pharmacy services among diabetes patients with poor adherence to CVD risk factor medications in 3 health care systems: Kaiser Permanente Northern California, Harvard Pilgrim, and Kaiser Permanente ...
What is the current status of trial NCT02621476?
This trial is currently completed. It is a NA study. The enrollment target is 63,012 participants. The study started on 2017-02-01. Estimated completion is 2022-05-30.
What interventions are being tested in trial NCT02621476?
The interventions under investigation include: Usual care (BEHAVIORAL), Standardized intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02621476?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02621476's enrollment target sits among peer trials
63,012 4th of 2000 higher than 1,997 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06003192 · 63,000 participants · NA
Screen Smart: Using Digital Health to Improve HIV Screening and Prevention
- NCT05128006 · 63,200 participants
Direct-to-patient Teledermatology and Computer-assisted Diagnosis
- NCT05723614 · 61,770 participants · NA
TRUsted rEsidents and Housing Assistance to Decrease Violence Exposure in New Haven
- NCT04473833 · 65,000 participants · NA
Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI